Patent Valuation Attorney — Austin, Texas
Understanding the economic value of your patent or patent portfolio is essential for licensing negotiations, investment transactions, litigation damages, and strategic portfolio decisions — accurate patent valuation requires both legal expertise and genuine technical understanding of what the patents actually protect in the relevant market.
Home → Practice Areas → Patent Valuation
Factors That Determine Patent Value
Patent value is driven by multiple factors working together. Claim scope and breadth determine how much technology the patent actually protects — broadly drafted claims that cover the market-relevant implementation are worth far more than narrow claims that competitors can easily design around. Remaining patent term affects how many years of exclusivity the patent provides. Technology relevance assesses whether the patented technology is central to current products and likely future developments.
Licensing history and comparables provide market evidence of what similar patents have been licensed for. The competitive landscape — including what alternatives are available to potential licensees — affects how much leverage the patent holder has in licensing negotiations. Enforcement history indicates whether the patent has been tested in litigation and how it performed. My engineering background allows me to assess the technical dimensions of these factors accurately for patents in semiconductor software optics and medical device fields.
Patent Valuation for Licensing Negotiations
In patent licensing negotiations the parties' respective assessments of the patent's value determine the commercially reasonable royalty rate and license terms. A patent holder with genuinely strong broadly-claimed patents covering core market technology has significant negotiating leverage. A patent holder with narrow claims that competitors can easily design around has much less. Understanding which situation you are in requires both legal claim analysis and technical assessment of the patent's actual coverage of the relevant market.
I provide patent valuation analysis specifically tailored to support licensing negotiations — assessing claim scope against actual market implementations evaluating invalidity risk that affects negotiating leverage and identifying comparable license transactions that provide market evidence of reasonable royalty rates. This analysis gives clients the factual and analytical foundation to negotiate from an informed position rather than guessing at their patent's value.
Valuation for Investment and Acquisition Transactions
For technology companies where IP is a primary value driver patent portfolio valuation is a critical component of transaction pricing. Investors and acquirers need to understand what the patent portfolio is actually worth — not just how many patents the company holds but whether those patents provide genuine competitive protection in the relevant markets.
I provide patent portfolio valuation analysis for startup investors evaluating IP-heavy technology companies corporate acquirers assessing target company patent portfolios and companies preparing for fundraising or acquisition who want to understand and articulate the value of their IP assets. My engineering background is particularly valuable for portfolios in semiconductor software optics and medical device fields where technical claim assessment requires genuine engineering expertise.
Patent Valuation in Litigation
In patent infringement litigation damages calculations often require patent valuation analysis. The reasonable royalty standard — which asks what a reasonable royalty would have been in a hypothetical negotiation between the parties at the time infringement began — requires assessing the value of the patent to both parties at that hypothetical negotiation. Expert testimony on reasonable royalty damages typically involves detailed patent valuation analysis.
I provide patent valuation analysis to support litigation damages calculations working with damages experts and litigation counsel to develop technically grounded assessments of patent value. My engineering background is particularly valuable in technically complex cases where the technical dimensions of the Georgia-Pacific factors — the standard framework for reasonable royalty analysis — require genuine technical understanding of the patented technology and its alternatives.
Coordinating Valuation With Portfolio Strategy
Patent valuation analysis should inform ongoing portfolio management decisions — not just be conducted as a one-time exercise for a specific transaction. Understanding the relative value of different patents in your portfolio helps you make better decisions about where to invest prosecution resources which patents to maintain which to license and which to abandon.
I integrate valuation analysis into portfolio management services for clients with established patent portfolios — providing periodic assessment of portfolio value and how it is evolving over time. This ongoing valuation perspective ensures that portfolio decisions are grounded in a realistic assessment of IP value rather than historical filing patterns that may no longer reflect current technology and market realities.
[ Patent Valuation FAQs — Austin, Texas ]
Question: How is patent value determined?
Answer: Patent value depends on claim scope remaining term technology relevance competitive alternatives licensing history and enforceability among other factors. I assess both the legal and technical dimensions of these factors to provide a grounded valuation analysis rather than a purely formulaic approach.
Question: Do I need a formal patent valuation for licensing negotiations?
Answer: A formal written valuation is not always required but a thorough analytical assessment of your patent's strengths and weaknesses is essential for effective licensing negotiation. Entering negotiations without understanding your patent's actual value is like negotiating a real estate sale without knowing the property's market value.
Question: Can patent value change over time?
Answer: Yes — patent value changes as the technology landscape evolves remaining term decreases competitor products develop and licensing market comparables accumulate. A patent that was highly valuable when granted may become less so as the technology becomes commoditized or as better alternatives emerge.
Question: How does the remaining patent term affect the royalty rate in a licensing negotiation?
Answer: Remaining patent term is one of the most significant factors affecting licensing leverage and negotiated royalty rates — a patent with 18 years of remaining term provides substantially more licensing leverage than the same patent with 2 years remaining, all else being equal. The economic value of a patent license is the present value of the royalty stream over the term during which the licensee can be required to pay — which is directly proportional to the remaining term. However the relationship between remaining term and royalty rate is not simply linear because patent value is not evenly distributed across its term — a patent covering a technology at its commercial peak early in its term may command higher royalties per year than the same patent covering a declining technology late in its term. I assess remaining term in the context of the technology's commercial lifecycle — remaining term times expected commercial relevance provides a more accurate value indicator than remaining term alone.
Question: What is the relationship between patent claim scope and the reasonable royalty calculation in litigation?
Answer: The reasonable royalty in patent litigation is calculated under the Georgia-Pacific factors framework, several of which are directly affected by patent claim scope. A patent with broad independent claims that cover the core technology without close alternatives — where the licensee cannot practice the relevant technology without licensing the patent — supports higher royalty rates under the Georgia-Pacific analysis than a patent with narrow claims covering only one specific implementation that competitors can easily design around. Claim scope also affects the royalty base: the entire market value rule — which allows royalties to be calculated on the entire product's value when the patented feature drives customer demand — requires that the claimed invention be the basis for customer demand. Narrow claims covering peripheral features cannot support entire product royalty bases regardless of the product's overall commercial success. I assess claim scope specifically in the context of reasonable royalty analysis — identifying whether the claims support broad or narrow royalty bases and what royalty rate range the scope and commercial significance of the claims would support under Georgia-Pacific.
Question: How do you value a patent portfolio when some patents have already been asserted in litigation?
Answer: Previously asserted patents have valuation characteristics distinct from un-asserted patents — in both positive and negative directions. Positively, an asserted patent has established litigation-tested claim construction and potentially survived invalidity challenges that demonstrate its robustness — which increases valuation certainty compared to an un-asserted patent whose litigation strength is untested. Negatively, a patent that was asserted and resulted in an unfavorable claim construction, or that survived litigation only with significantly narrowed claims, may have reduced effective scope compared to its original face value. A patent asserted in litigation that produced a favorable settlement provides transaction comparable data — the settlement amount is direct evidence of what a sophisticated defendant valued the patent's risk at. I assess litigation history as a specific valuation input — analyzing the judicial or PTAB record for claim construction outcomes, validity determinations, and damages assessments that affect the patent's forward value.
Question: What is the difference between using the income approach versus the market approach for patent valuation in an Austin startup context?
Answer: For early-stage Austin startups without licensing revenue history, the income approach — projecting royalty income and discounting to present value — requires speculative revenue projections that significantly affect the valuation's reliability. Market approach valuations using comparable transactions are more grounded in actual market evidence but require finding comparable patent transactions, which is challenging for highly specific technology patents in Austin's emerging sectors. In practice, early-stage startup patent valuation for fundraising purposes is less about producing a precise dollar figure and more about demonstrating that the portfolio covers commercially significant technology with meaningful claim scope and freedom to build on. I advise early-stage Austin clients to focus patent portfolio development on the qualitative factors that investors actually assess — claim breadth, prosecution status, FTO clearance, and continuation strategy — rather than on formal valuation analysis that produces spuriously precise numbers for early-stage portfolios.
Question: What is a patent's blocking value and how do I quantify it in a portfolio assessment?
Answer: A patent's blocking value — its ability to prevent competitors from practicing technology they would otherwise use — is distinct from its licensing value and frequently more important for operating companies whose primary objective is maintaining competitive market position rather than generating royalty revenue. Quantifying blocking value requires assessing what the competitor would need to do if your patent were enforced against them: design around the patent at specific engineering cost, license the patent at a negotiated royalty, or exit the market segment covered by the patent. A patent blocking access to a technology where design-arounds are technically infeasible or commercially unacceptable has high blocking value regardless of what royalty rate it might command in a licensing negotiation. I assess blocking value specifically by analyzing the technical design-around feasibility given the claims' breadth and the competitive product's architecture — engineering judgment that requires genuine understanding of both the patent's claim scope and the competitive product's technical implementation. These two dimensions of patent value can both be present simultaneously but are sometimes in tension — aggressively blocking competitors with a patent prevents you from collecting licensing revenue from them.
Answer: Cross-market patents — covering technology implemented in semiconductor, automotive, consumer electronics, and medical device applications simultaneously — present specific valuation complexities because the commercial value in each market segment may differ dramatically. A patent on a sensor technology might have modest value in the consumer electronics market where the technology is a commodity and alternative approaches exist, but substantial value in the medical device market where the specific technical approach enables clinical performance that alternatives cannot match. Multi-segment valuation requires analyzing the technology's competitive position and commercial significance in each segment independently and then assessing the combined value considering the interdependencies — specifically whether the patent must be licensed to competitors in each segment simultaneously or whether the patent holder can segment the licensing program by market. I conduct multi-segment patent valuations with segment-specific commercial and technical analysis rather than applying a single value across all markets.
Question: How does patent valuation change when a patent covers technology in multiple market segments?
Answer: Patent litigation damages experts — typically financial or economic consultants with expertise in patent royalty analysis — provide the formal damages testimony in federal court patent cases. My role in supporting patent damages expert testimony is the technical foundation that the damages analysis rests on: claim construction analysis establishing what the patent actually covers, technical analysis mapping the patent's claims to the accused products to establish the royalty base, comparable license analysis identifying the most technically similar licensing transactions in the record, and assessment of the technical design-around options available to the defendant that affect the royalty rate. As of counsel to litigation firms handling Austin patent cases, I provide the technical patent analysis that supports the financial expert's damages model — ensuring that the damages analysis is grounded in technically accurate claim scope assessment rather than an attorney's approximation of what the patent covers.
Question: What is the role of expert testimony in patent valuation for litigation damages and how does the Law Office of Sean Christian Connolly support that process?
Question: What are the three main approaches to patent valuation and when is each used?
Answer: Patent valuation uses three primary approaches borrowed from traditional asset valuation. The income approach values patents based on the income they are expected to generate — typically through discounted cash flow analysis of projected licensing royalties or the profit premium attributable to the patented technology over non-patented alternatives. This approach is most appropriate when reliable revenue projections are available and when the patent's income-generating mechanism is clear. The market approach values patents based on comparable transactions — what similar patents have sold for or been licensed for in arm's length transactions. This approach requires adequate comparable transaction data, which is often limited for highly specific technology patents. The cost approach values patents based on the cost to develop or replace the patented technology — most appropriate for early-stage patents where commercial value is uncertain. Different valuation contexts often call for different approaches or combinations of approaches.
Question: What is a reasonable royalty and how is it calculated?
Answer: A reasonable royalty in the patent context is the royalty rate that a willing licensor and willing licensee would have agreed to in a hypothetical negotiation at the time infringement began — with both parties knowing the patent is valid and infringed. In patent litigation, reasonable royalty damages are calculated using the Georgia-Pacific factors — a 15-factor analytical framework that considers the royalty rates established in the industry, comparable license transactions, the patent's commercial importance to the infringer's product, the profitability of the licensed product, the opinion of qualified experts, and other relevant factors. In licensing negotiations outside litigation, reasonable royalty analysis provides a factual foundation for royalty rate demands that are grounded in economic analysis rather than arbitrary positions.
Question: What is a royalty base and why does it matter in patent licensing?
Answer: The royalty base is the revenue amount to which the royalty rate is applied to calculate the royalty payment — and its definition can be as commercially significant as the royalty rate itself. Common royalty base options include net sales of the complete product incorporating the patented technology, net sales of the specific component that practices the patented technology, or specific units of the claimed technology rather than revenue. The choice of royalty base can dramatically affect the total royalty payment — a 1% royalty on total product revenue generates very different payments than a 1% royalty on the component value alone. In patent litigation, the entire market value rule and apportionment principles affect what royalty base is legally appropriate. I advise clients on royalty base definitions in licensing negotiations based on what is both commercially justifiable and legally defensible.
Question: What are comparables in patent valuation and where do I find them?
Answer: Comparables in patent valuation are prior arm's length license transactions involving patents in the same or similar technology areas that can provide market evidence of what a willing buyer and willing seller would agree to for the subject patents. Finding reliable comparables is often the most challenging aspect of patent valuation — most license transactions are private and their terms are confidential. Public sources of comparable transaction data include SEC filings that disclose material licensing transactions and their terms, patent litigation damages verdicts and settlement amounts reported in court records, the intellectual property owner association and licensing executives society surveys of royalty rates by technology area, and commercial patent transaction databases. I use these sources combined with technical analysis of the subject patents' comparability to identified transactions to develop royalty rate positions grounded in market evidence.
Question: What is a patent's remaining useful life and how does it affect valuation?
Answer: A patent's remaining useful life combines its remaining legal term — the years left before the patent expires — with an assessment of how long the underlying technology is likely to remain commercially relevant. A patent with 15 years of remaining legal term covering foundational semiconductor architecture that will be practiced for the next 20 years has a high remaining useful life. A patent with 15 years of remaining legal term covering a specific software implementation that the market is rapidly abandoning has a lower remaining useful life despite the same legal term. Remaining useful life affects the projected royalty income available from the patent over its remaining term, which directly affects income approach valuations. It also affects the licensing leverage available to the patent holder — a patent holder whose key patents are expiring soon has less leverage than one with significant remaining term.
Question: How does claim scope affect patent valuation?
Answer: Claim scope is arguably the most important driver of patent value — a patent's claims define the legal boundaries of what is protected, and those boundaries determine how broadly the patent covers the relevant market. Broadly drafted claims that cover the core innovation in a way that encompasses all commercially relevant implementations have significantly more value than narrowly drafted claims that competitors can easily design around. Assessment of claim scope for valuation purposes requires both legal claim construction analysis — determining what the claims actually mean under proper interpretation — and technical analysis of what products and processes fall within that scope. My combination of legal patent expertise and engineering background allows me to assess claim scope in semiconductor, software, and medical device patents with the technical accuracy that reliable valuation requires.
Question: What is the difference between a patent's book value and its fair market value?
Answer: A patent's book value is the accounting value recorded on a company's balance sheet — typically the capitalized costs of obtaining the patent including patent prosecution attorney fees and USPTO fees, amortized over the patent's expected useful life. Book value rarely reflects economic reality — a patent obtained for $20,000 in prosecution costs might be worth $50 million in licensing revenue potential, while another patent obtained for the same cost might be essentially worthless if the technology has been superseded. Fair market value is what a willing buyer would pay and a willing seller would accept in an arm's length transaction with both parties fully informed — which depends on the patent's commercial significance, claim scope, remaining term, validity risk, and the specific competitive context, not on its accounting cost.
Question: How does patent valuation account for the risk of invalidity?
Answer: Invalidity risk is a significant downward factor in patent valuation — a patent that is likely to be challenged and invalidated has lower value than a patent with the same claim scope and commercial coverage that is highly defensible against invalidity challenges. Valuation models incorporate invalidity risk through probability-adjusted royalty projections — discounting the expected royalty income by the probability that the patent will survive validity challenge. Technical prior art analysis, prosecution history estoppel assessment, and evaluation of specific invalidity arguments available against the patent are the inputs to the invalidity risk factor. I assess invalidity risk as an integrated component of patent valuation — providing both the commercial coverage analysis and the validity risk assessment needed for a complete valuation picture.
Question: How should I prepare for a patent valuation engagement?
Answer: Preparing for a patent valuation engagement involves assembling the documentation I need to conduct a comprehensive analysis — including the complete prosecution file history for each patent being valued (available from the USPTO's Patent Center), any licensing agreements covering the subject patents, any litigation or assertion history involving the patents, commercial information about the products or processes practicing the patents, competitive market information including competitor products and their relationship to the patent claims, and any prior valuation analyses that have been conducted on the same patents. The more complete the documentation provided at the outset, the more accurate and efficient the valuation analysis. I discuss specifically what documentation is most important during your initial consultation based on the specific patents being valued and the purpose of the valuation.
Question: Can I use patent valuation to justify a higher price in a licensing negotiation?
Answer: Yes — and having a credible valuation analysis is one of the most effective tools for supporting your licensing demands. Licensing demands unsupported by economic analysis are easy to dismiss as arbitrary. Licensing demands supported by a thorough valuation analysis — citing comparable transactions, demonstrating the commercial coverage of the claims against the licensee's specific products, and projecting the reasonable royalty based on defensible economic methodology — are harder to dismiss and create a factual foundation for negotiation. I develop licensing position analyses for patent holders preparing for licensing negotiations that are grounded in economic analysis and specifically tailored to the licensee's situation, providing the credibility that moves licensing conversations from positional argument to principled negotiation.
Question: What is a portfolio valuation versus an individual patent valuation?
Answer: An individual patent valuation assesses the standalone commercial value of a specific patent or patent application — its claim scope, remaining term, validity risk, and the specific market coverage it provides. A portfolio valuation assesses the collective value of a company's entire patent holdings — including not just the sum of individual patent values but the portfolio's collective strategic value, which can be greater than the sum of its parts when patents cover overlapping technology in complementary ways that create a more complete competitive protection than any individual patent provides. Portfolio valuations also assess the portfolio's defensive value — its ability to deter competitor assertions through cross-licensing leverage — which individual patent valuations do not capture. For Austin startup acquisition and investment contexts, portfolio valuation is typically more relevant than individual patent valuation because acquirers and investors assess the portfolio's contribution to overall business defensibility rather than the value of specific individual assets.
Answer: Citation analysis examines how frequently a patent is cited by subsequent patent applications as prior art — a commonly used quantitative metric for assessing a patent's technological influence and potential commercial significance. Patents that are heavily cited by subsequent filings in the same technology area are considered influential — their technical contributions are recognized by subsequent inventors in the field. High forward citation count is associated with broader claim scope, foundational technical contributions, and greater commercial relevance. Citation analysis is one quantitative input to patent valuation — not a definitive valuation metric but a useful signal of technological significance. For Austin semiconductor and software patent portfolios where citation databases provide substantial citation data, I incorporate citation analysis as one component of a multi-factor valuation framework alongside claim scope analysis, market coverage assessment, and comparable transaction data.
Question: What is a citation analysis and how does it contribute to patent valuation?
Question: What is the difference between patent value and patent price in a licensing or acquisition context?
Answer: Patent value is the economic benefit that a patent provides to its holder — the income it generates through licensing, the competitive advantage of exclusivity, or the litigation leverage it provides in enforcement or defensive contexts. Patent price is what someone is willing to pay for ownership or a license to those rights in a specific transaction. Value and price can diverge significantly — a patent may have high intrinsic value to a specific acquirer because of how it complements their existing portfolio or product line, creating a transaction price that exceeds the patent's standalone market value. Conversely, a patent with high potential licensing value may transact at a lower price if the patent market is illiquid or if the seller faces urgent liquidity needs. For Austin companies buying or selling patent assets, understanding the distinction between value and price — and the specific factors that create a premium or discount in the specific transaction context — is essential for achieving commercially optimal outcomes.
Question: What is a patent's defensive value versus its offensive value in a valuation?
Answer: Defensive value measures how much a patent contributes to protecting its holder from assertion by others — specifically, how much cross-licensing leverage it provides against competitors who might otherwise assert their own patents and how much FTO protection it provides by establishing prior art that limits others' patent scope. Offensive value measures how much a patent contributes to the holder's ability to assert rights against others — through enforcement, licensing, or competitive exclusion. Defensive value is particularly significant for large technology companies whose primary patent concern is protecting their freedom to operate rather than generating licensing revenue. Offensive value is more significant for companies whose business model includes patent licensing and enforcement. A comprehensive patent valuation assesses both dimensions — a patent with limited offensive scope may still have significant defensive value if it covers technology in an area where competitors hold strong offensive patents.
Question: How does the patent litigation risk affect patent valuation in the current environment?
Answer: Patent litigation risk affects valuation in both directions. For patent holders seeking to monetize through licensing or assertion, the realistic cost of patent litigation — hundreds of thousands to millions of dollars for full district court litigation — determines the minimum licensing demand that makes economic sense rather than litigation. Patents covering technology where litigation is expensive to prove and defend command higher minimum licensing thresholds than patents in simpler technology areas. For potential licensees assessing whether to license proactively or wait to be sued, the expected litigation cost and duration affects the licensing value they are willing to accept versus the risk of litigation. The current PTAB IPR environment — which provides a relatively affordable path to patent invalidation — affects the litigation risk calculation for both sides by creating a credible invalidity threat that constrains licensing demands and affects the economic calculus of patent enforcement.
Question: What is a renewal or maintenance fee analysis in patent portfolio valuation?
Answer: Maintenance fee analysis assesses the ongoing cost of keeping a patent portfolio in force — the USPTO's scheduled maintenance fees at 3.5, 7.5, and 11.5 years after grant — relative to the commercial value each patent provides for the remaining maintenance fee periods. In portfolio valuation, maintenance fee analysis identifies patents that are consuming ongoing resources disproportionate to their commercial value — candidates for strategic abandonment that reduces portfolio maintenance costs while concentrating resources on the most valuable assets. For large acquired patent portfolios, the present value of all future maintenance fee obligations can represent a significant financial liability that affects the portfolio's net value to the acquirer. I conduct maintenance fee analysis as a standard component of portfolio valuation engagements — providing both a cost liability assessment and a rationalization recommendation identifying which patents justify their ongoing maintenance costs.
Question: How do standard essential patents differ in valuation from non-essential patents?
Answer: Standard essential patents — patents covering technology necessarily implemented by anyone practicing a specific industry standard — have fundamentally different valuation characteristics than non-essential patents. SEPs typically must be licensed on fair, reasonable, and non-discriminatory terms — the FRAND obligation imposed by most standards-setting organizations as a condition of including the technology in the standard. FRAND licensing constrains the patent holder's ability to command above-market royalties that the exclusivity of a strong patent might otherwise support. However, SEPs have the unique advantage of guaranteed licensing demand — every implementer of the standard must license the SEP regardless of whether they could design around it. SEP valuation therefore focuses on what FRAND royalty rate is justified for the specific patent's contribution to the standard, rather than the market-exclusion value that drives non-SEP valuation. The FRAND royalty calculation requires both legal analysis of applicable FRAND jurisprudence and technical analysis of the patent's contribution to the standard's overall functionality.
Question: What is a technology life cycle analysis and how does it affect patent valuation?
Answer: Technology life cycle analysis assesses where a specific technology stands in its development and adoption trajectory — early stage with significant growth potential, mature with stable adoption, or declining with replacement technologies emerging. Patent valuation must account for the technology life cycle because a patent's commercial relevance is tied to the commercial relevance of the underlying technology. A patent on a technology at the peak of its adoption curve has maximum commercial value — broad market implementation generates licensing revenue potential. A patent on technology that the market is abandoning in favor of superior alternatives has declining value even if its claims are broad and it has significant remaining term. For Austin semiconductor and software patent portfolios where technology generations turn over quickly, technology life cycle analysis is particularly important — a portfolio that was commercially significant five years ago may need significant rationalization and refreshing to remain relevant to the current competitive landscape.
Question: How does a patent valuation account for continuation applications still pending?
Answer: Active continuation applications in a patent family represent contingent future value — the possibility that additional patents with potentially broader or differently directed claims will issue, extending and deepening the portfolio's coverage. Patent valuation for a family with active continuations must assess both the current value of issued patents and the option value of pending continuations — the probability-adjusted expected value of the additional coverage that continuation patents may provide when issued. Continuation option value is highest when the original specification is comprehensive — supporting a broad range of potential future claims — and when the prosecution strategy is actively managed to pursue continuation claims directed at emerging competitor products and market developments. For Austin companies acquiring or licensing patent portfolios, the presence of active continuation applications in key technology areas is a positive valuation factor that represents ongoing portfolio development rather than a static asset.
[ Schedule a Free Consultation ]
Patent Valuation Services
Understanding the economic value of your patent or patent portfolio is essential for licensing negotiations, investment transactions, litigation strategy, and informed portfolio management decisions — and accurate patent valuation requires both legal expertise and genuine technical understanding of what the patents actually protect.
I offer a free 30-minute consultation to discuss your valuation need — whether for an upcoming licensing negotiation, a transaction, litigation support, or portfolio strategy — and to assess what a thorough valuation analysis would involve for your specific patents and technology area.
My engineering background allows me to assess the technical dimensions of patent value accurately — evaluating actual claim coverage of market-relevant implementations rather than simply characterizing patents by their face value.
Call or text (512) 293-0710, email sconnolly@austin-patent-attorney.com, or fill out the form.
Phone: 512-293-0710
Email: sconnolly@austin-patent-attorney.com
Location: Austin, Texas
Serving Austin, Round Rock, Cedar Park, Georgetown, and all of Central Texas.
USPTO matters are federal — I work with clients throughout Texas and nationwide.
[ Related Services ]
Clients valuing patent assets often also work with me on:
[Patent Licensing Agreements] · [IP Due Diligence] · [Patent Portfolio Management] · [Inter Partes Review Support] · [Freedom to Operate Opinions]
What Is Patent Valuation?
Patent valuation is the process of determining the economic value of a patent or patent portfolio for a specific purpose — licensing negotiations investment or acquisition transactions litigation damages calculations tax planning or strategic IP portfolio decisions. Unlike tangible assets patents are intangible and their value depends on a complex interplay of legal technical commercial and market factors that require specialized expertise to assess accurately.
Patent valuation is both a legal analysis and a technical assessment. The legal component evaluates claim scope and breadth prosecution history estoppel remaining patent term and enforceability. The technical component assesses the relevance of the technology to current and future markets the competitive alternatives available to potential licensees and the technical barriers to designing around the claimed invention. My combination of legal expertise and engineering background makes patent valuation analysis in technically complex fields significantly more accurate.
